Advertisement
Home 2015

Archives

Watching television

PAS: Even One Hour of TV a Day Ups Childhood Obesity Risk

0
Odds increase nearly 50 percent with 60 minutes or more of daily screen time
Many breast cancer patients who are eligible for breast-conserving surgery still choose to have the entire breast removed

Women Eligible for Lumpectomy Still Choosing Mastectomy

0
Better pre-surgical chemotherapy means more of the breast can safely be saved, researchers say
Despite evidence that has suggested metformin might have potential in cancer

AACR: Metformin Benefit Lacking in Pancreatic Ductal CA

0
Survival not significantly different for pancreatic ductal adenocarcinoma patients
Black women are more likely than white women to have dense breasts

AACR: Dense Breasts Found More Likely in Black Women

0
Finding may help explain greater breast cancer risk in this population, researchers say
One in 10 people worldwide will have a seizure in their lifetime

AAN: New AAN/AES Guidelines on Treating First Seizure

0
Antiepileptic drug therapy recommended to help stave off recurrence
Longer nighttime fasting duration is associated with improved glycemic regulation

AACR: Longer Nighttime Fasting May Reduce Breast Cancer Risk

0
Improving biomarkers of glycemic control thought to decrease breast cancer risk
Taking aspirin regularly over several years may help prevent gastrointestinal cancers

AACR: Regular Aspirin Use Linked to Lower GI Cancer Risk

0
Greatest benefit from aspirin required taking it for at least 16 years
Programmed cell death 1 inhibition with pembrolizumab is showing early promise for some patients with advanced non-small-cell lung cancer

AACR: Pembrolizumab Shows Promise in Advanced Lung Cancer

0
Keytruda (pembrolizumab) is already approved to treat melanoma
The number of U.S. women diagnosed with breast cancer could rise by as much as 50 percent within the next 15 years

AACR: Changes Expected in Breast Cancer Rates

0
Overall, breast cancer could rise by as much as 50 percent within the next 15 years
Immune checkpoint inhibitors show promise in treating advanced melanoma

AACR: Immune Checkpoint Inhibitors Promising in Melanoma

0
Pembrolizumab, ipilimumab, and other medications harness immune cells to target cancers